Introduction 7.5032105
: 2.7003784
Ċ 1.1506985
Mel 14.493752
an 1.7879621
oma 1.6036057
, 3.4508562
Ġa 1.6846768
Ġform 2.4429936
Ġof 0.0031055345
Ġskin 0.19653727
Ġcancer 0.010836174
, 0.20713218
Ġhas 2.4446151
Ġexperienced 6.273016
Ġsignificant 3.4442499
Ġadvancements 6.6456223
Ġin 0.14643997
Ġtreatments 4.708976
Ġin 2.041802
Ġrecent 0.8497723
Ġyears 0.13772073
. 0.39309546
ĠAmong 5.0131974
Ġthese 0.875545
Ġadvancements 1.1714008
, 1.8797573
Ġimmune 4.3170257
Ġcheckpoint 0.6514553
Ġinhibitors 0.34563035
Ġand 4.276392
Ġadj 6.147777
u 0.14658979
vant 0.0004337889
Ġtherapies 1.1657968
Ġhave 0.56200963
Ġemerged 3.1375058
Ġas 0.14287953
Ġpromising 1.9084306
Ġapproaches 3.8711622
. 1.8468723
ĠThis 3.5398262
Ġessay 5.7878995
Ġexplores 3.6904821
Ġthe 0.442561
Ġpotential 4.082189
Ġbenefits 3.3389366
Ġof 0.7258922
Ġthese 2.33952
Ġtreatments 1.6041917
, 1.4702197
Ġtheir 3.4502165
Ġimplications 5.3731937
Ġfor 0.9902294
Ġpatients 2.5385168
Ġat 7.0123763
Ġdifferent 1.5835755
Ġstages 0.23308378
Ġof 0.1709871
Ġmelan 0.7197312
oma 0.004392277
, 0.3699311
Ġand 0.17628288
Ġtheir 1.8335859
Ġimpact 4.32938
Ġon 0.056010097
Ġimproving 5.739605
Ġsurvival 1.6053274
Ġrates 0.6347052
. 0.41053334
ĠFurthermore 5.146158
, 0.0064658327
Ġit 1.750826
Ġwill 1.7966927
Ġdraw 6.5870533
Ġon 1.7993673
Ġresearch 3.6805785
Ġevidence 3.8038619
Ġand 1.8813393
Ġanalyze 7.7393775
Ġthe 0.83703434
Ġcase 6.7618384
Ġof 0.4531074
ĠMr 4.9084296
. 0.19338444
ĠB 3.475209
Ġas 5.2390456
Ġan 0.9782727
Ġillust 3.3242824
rative 0.00041494548
Ġexample 0.17093986
. 0.63499135
Ċ 0.60389084
Body 7.230269
: 0.016054949
Ċ 0.15084824
I 4.8596783
. 0.07141493
ĠImm 1.8374718
une 0.0007894305
ĠCheck 0.56454384
point 0.069779105
ĠIn 0.07060238
hib 0.016745668
itors 0.028876944
: 1.7099029
Ċ 0.5638726
A 1.891136
. 0.076650254
ĠMechan 3.9302619
ism 0.2530447
Ġof 0.3151622
ĠAction 0.250752
: 0.4121443
Ċ 0.16453728
Imm 0.6321783
une 0.0067193885
Ġcheckpoint 0.12317832
Ġinhibitors 0.050218444
, 2.3194377
Ġsuch 1.4621848
Ġas 0.0022642764
Ġp 2.7967367
emb 0.0022987493
rol 0.004279253
iz 0.0004197157
um 0.0051209503
ab 0.0003288449
Ġand 0.88851905
Ġn 0.10910163
iv 0.0005433961
ol 0.00012739444
um 0.018698465
ab 0.0008595825
, 0.12607491
Ġaim 5.431424
Ġto 0.037041318
Ġenhance 2.8763554
Ġthe 0.48349878
Ġbody 1.2631238
's 0.0058922963
Ġimmune 0.68763715
Ġresponse 0.4313998
Ġagainst 1.3135031
Ġmelan 1.6671065
oma 0.03019703
Ġcells 1.4451292
Ġby 1.4619784
Ġblocking 1.3225652
Ġthe 1.4122869
Ġsupp 6.5540166
ressive 0.00025574747
Ġsignals 2.6279123
Ġimposed 6.532693
Ġby 0.23789492
Ġspecific 3.7969468
Ġimmune 1.8730512
Ġcheckpoints 2.1010585
, 2.0618508
Ġlike 5.5424156
ĠPD 1.0040962
- 0.049174625
1 0.16249555
/ 4.044015
PD 0.02068983
- 0.051685754
L 0.016219527
1 0.006547785
Ġand 1.5189805
ĠCT 0.0393646
LA 0.0004190014
- 0.06886143
4 0.0012080359
. 0.47549087
Ċ 2.5258389
B 4.124391
. 0.016867686
ĠEffect 5.14062
iveness 0.16095632
Ġand 2.5656118
ĠLong 5.9109483
- 0.16209294
term 1.0253294
ĠRem 5.771321
ission 0.7285538
: 0.47239184
Ċ 0.031126115
Research 3.1983469
Ġhas 1.3143047
Ġshown 0.7308747
Ġsubstantial 8.141011
Ġpromise 2.7108083
Ġin 1.0694754
Ġimmune 3.1315322
Ġcheckpoint 0.015200125
Ġinhibitors 0.46260607
, 1.644503
Ġleading 4.2382927
Ġto 0.14134973
Ġimpressive 5.18646
Ġresponse 1.8103672
Ġrates 0.09357924
Ġand 1.0794086
Ġdurable 3.4993215
, 4.1530037
Ġlong 0.11140859
- 0.021666229
term 0.10601586
Ġremission 1.933456
Ġin 1.283325
Ġpatients 1.0092559
Ġwith 0.7813213
Ġadvanced 0.78960514
Ġmelan 0.257095
oma 0.008766781
. 0.22577643
ĠClinical 4.8855734
Ġtrials 0.33709723
Ġdemonstrated 3.9612854
Ġa 2.5991976
Ġsignificant 4.547406
Ġsurvival 2.2698987
Ġadvantage 0.8219408
Ġfor 1.2106501
Ġpatients 0.5160921
Ġtreated 1.2014112
Ġwith 0.012837472
Ġp 2.301116
emb 0.002289846
rol 0.008885782
iz 0.00082516216
um 0.0020822638
ab 0.0001390797
Ġand 1.7925036
Ġn 0.0948987
iv 0.0010010353
ol 0.00027327676
um 0.005411739
ab 5.8725527e-05
Ġcompared 1.126526
Ġto 0.1776329
Ġtraditional 4.4439754
Ġtherapies 1.8607961
. 0.996938
Ċ 1.6704023
C 1.287413
. 0.016240729
ĠImpl 2.6609187
ications 0.030509949
Ġfor 0.4622118
ĠPatients 0.94895995
Ġat 0.6027818
ĠDifferent 0.04420661
ĠSt 0.032523222
ages 0.0014393091
: 1.5047404
Ċ 0.018646603
1 3.941898
. 0.4654725
ĠAdvanced 3.9955852
ĠMel 1.0285889
an 4.29881e-05
oma 0.0017277149
: 0.35074994
ĠImm 6.7445292
une 9.4849514e-05
Ġcheckpoint 0.014617453
Ġinhibitors 0.0572417
Ġhave 0.95984447
Ġproven 2.5554738
Ġparticularly 2.4613771
Ġeffective 0.38584396
Ġin 0.5727873
Ġpatients 1.0828044
Ġwith 0.12116125
Ġadvanced 0.12314123
Ġor 4.8038445
Ġmetast 0.10024125
atic 0.0030755773
Ġmelan 0.327086
oma 0.0032772678
, 1.3411814
Ġachieving 3.584062
Ġhigher 3.9271894
Ġresponse 0.23189184
Ġrates 0.13864346
Ġand 0.6447386
Ġsuperior 5.0255866
Ġoverall 2.3766131
Ġsurvival 0.025892885
Ġcompared 1.2958714
Ġto 0.0948546
Ġstandard 3.5460558
Ġtreatments 1.2348793
. 0.43017596
Ċ 1.2073781
2 0.2875571
. 0.0013410042
ĠEarly 2.81645
- 1.4087927
stage 0.67740643
ĠMel 0.12204061
an 3.357061e-05
oma 0.0013874401
: 0.05270611
ĠStudies 4.319207
Ġare 3.3622959
Ġunderway 3.1638904
Ġto 0.16609973
Ġinvestigate 2.3149664
Ġthe 0.35187915
Ġpotential 2.2841299
Ġrole 2.6971397
Ġof 0.086334534
Ġimmune 0.11528326
Ġcheckpoint 0.0082216775
Ġinhibitors 0.031690486
Ġin 0.22737715
Ġadj 6.753682
u 0.027434835
vant 2.462996e-05
Ġtherapy 0.66989577
Ġsettings 8.966799
, 1.4366113
Ġwhich 3.1282182
Ġmay 2.154402
Ġimprove 2.747552
Ġoutcomes 2.735697
Ġand 2.728679
Ġreduce 1.7948523
Ġrec 1.0360553
urrence 0.053508725
Ġrates 0.70956594
Ġin 0.7398026
Ġpatients 0.35125208
Ġwith 0.17785363
Ġearlier 4.387701
Ġstages 1.225368
Ġof 0.014374647
Ġmelan 0.13460407
oma 0.0011750339
. 0.082388654
Ċ 0.26114485
II 1.365401
. 0.0036900982
ĠAd 0.2146944
ju 0.0025042836
vant 0.0032906635
ĠTher 1.4426985
ap 0.0039040584
ies 9.449002e-05
: 0.14569037
Ċ 0.019326061
A 0.050943866
. 0.0024278006
ĠComb 5.418352
ination 0.20730928
ĠTher 2.569596
ap 0.001490166
ies 4.430127e-05
: 0.119605616
Ċ 0.11859395
Comb 2.6931553
inations 3.123519
Ġof 0.036084764
Ġimmune 1.5826626
Ġcheckpoint 0.031004438
Ġinhibitors 0.049517293
Ġwith 1.2728751
Ġother 0.6705011
Ġadj 3.6525395
u 0.03321155
vant 1.3900239e-05
Ġtherapies 0.34640375
, 0.7998228
Ġsuch 0.33812696
Ġas 0.0012116159
Ġtargeted 2.4938364
Ġtherapies 0.6832525
Ġor 1.7664106
Ġradi 2.4275677
otherapy 0.052308787
, 0.056919795
Ġshow 3.567373
Ġpotential 3.101251
Ġin 1.1987878
Ġimproving 0.9592436
Ġtreatment 2.1654215
Ġoutcomes 0.23100638
Ġand 1.4116362
Ġpreventing 3.9653504
Ġtumor 2.999642
Ġrelapse 2.7413883
. 0.3299405
Ċ 0.44927943
B 0.011805409
. 0.00041494548
ĠEffect 5.439444
iveness 0.019278359
Ġin 2.9574103
ĠRed 4.527322
ucing 0.00022421066
ĠRec 0.69040567
urrence 0.028849274
: 0.73530614
Ċ 0.05251123
Cl 4.1522894
inical 0.005014792
Ġtrials 0.330435
Ġhave 0.6108982
Ġillustrated 5.2890997
Ġthe 0.9407702
Ġeffectiveness 1.5788273
Ġof 0.03665449
Ġadj 1.0857556
u 0.0054702894
vant 3.4167595e-05
Ġtherapies 0.60262
Ġin 0.18512815
Ġsignificantly 5.238506
Ġreducing 0.12545596
Ġthe 1.2645267
Ġrisk 0.48928398
Ġof 0.022544017
Ġrec 1.3226095
urrence 0.003919731
Ġin 0.8241211
Ġpatients 0.24026962
Ġwith 0.15150121
Ġhigh 3.8828027
- 0.16080308
risk 0.008146682
Ġmelan 0.8564935
omas 2.3530242
Ġafter 4.7930737
Ġsurgical 1.2601107
Ġremoval 0.73785996
. 0.67119044
Ċ 0.39059827
C 0.08308363
. 0.0006565927
ĠImpl 1.4346488
ications 0.02188449
Ġfor 0.14394294
ĠPatients 0.11216151
Ġat 0.08105233
ĠDifferent 0.013436571
ĠSt 0.0023275432
ages 1.8190814e-05
: 0.026188739
Ċ 0.013053456
1 0.0636972
. 0.0017102233
ĠIntermediate 6.504184
Ġto 4.86777
ĠHigh 1.0252529
- 0.2785988
risk 0.30603212
ĠMel 0.3398584
an 0.00010951312
oma 0.41801542
: 0.0696327
ĠAd 1.3019229
ju 0.0058319857
vant 0.0010552133
Ġtherapies 0.24823053
Ġhave 1.4001404
Ġshown 1.3061705
Ġpromising 1.4375957
Ġresults 0.38085082
Ġin 0.21328312
Ġimproving 2.5262833
Ġsurvival 1.4655077
Ġrates 0.588473
Ġand 1.1846893
Ġprolong 5.4715133
ing 0.002733528
Ġremission 1.6243755
Ġin 0.5990044
Ġpatients 0.25427094
Ġat 3.129237
Ġintermediate 0.9907983
Ġto 0.505609
Ġhigh 0.0098802745
- 0.61022264
risk 0.0039229635
Ġstages 1.8276148
Ġof 0.2835462
Ġmelan 0.03515907
oma 0.0026031807
, 2.364525
Ġreducing 4.5558324
Ġthe 0.28375733
Ġchances 3.6812093
Ġof 0.021771666
Ġrec 1.7352257
urrence 0.002580592
Ġand 1.2832404
Ġdisease 4.0953045
Ġprogression 0.240055
. 0.09752334
Ċ 0.07450454
2 0.22971275
. 0.00060369127
ĠLow 0.37797147
- 0.04366003
risk 0.054459747
ĠMel 0.07360941
an 3.559716e-05
oma 0.006465233
: 0.019254537
ĠThe 2.5892792
Ġrole 1.7490745
Ġof 0.02393585
Ġadj 0.023277184
u 0.009316035
vant 4.430127e-05
Ġtherapies 0.2561402
Ġin 0.51672786
Ġlow 0.93882114
- 0.018172136
risk 0.0052096792
Ġmelan 0.33137622
oma 0.51274014
Ġis 0.8982401
Ġnot 2.300004
Ġyet 1.4402617
Ġwell 1.4555126
- 0.80142134
established 0.8582572
. 0.82617307
ĠMore 2.608064
Ġresearch 0.5085515
Ġis 0.17044221
Ġneeded 0.42484716
Ġto 0.13134326
Ġdetermine 1.175125
Ġtheir 2.192666
Ġpotential 2.3978534
Ġbenefits 1.274043
Ġin 1.359774
Ġthis 1.2745564
Ġpatient 1.9179178
Ġpopulation 0.23251851
. 0.06633167
Ċ 0.053640157
III 0.6424604
. 0.002301616
ĠImpl 4.0983214
ications 0.015043942
Ġfor 1.1640805
ĠSurvival 6.4231386
ĠRates 0.6116241
Ġand 2.248259
ĠMr 3.5542643
. 0.009741233
ĠB 0.013450828
's 1.4556895
ĠCase 0.22109143
: 0.13730907
Ċ 0.01351245
A 0.72520524
. 0.009400563
ĠImpact 3.5556052
Ġon 0.5922248
ĠSurvival 0.32831585
ĠRates 0.09661701
: 0.08086871
Ċ 0.10027216
The 1.897187
Ġintroduction 3.57857
Ġof 0.07884903
Ġimmune 0.17854522
Ġcheckpoint 0.0049979594
Ġinhibitors 0.011197885
Ġand 0.24445955
Ġadj 0.08209842
u 0.0048964247
vant 2.7611111e-05
Ġtherapies 0.048569437
Ġhas 0.90542275
Ġsignificantly 1.7053257
Ġenhanced 3.7881596
Ġsurvival 1.5901479
Ġrates 0.05901303
Ġin 1.1154653
Ġpatients 0.28547883
Ġwith 0.07077619
Ġadvanced 0.5344075
Ġmelan 0.28501213
oma 0.011406161
. 0.4695893
ĠThese 3.7697034
Ġtreatments 1.2138761
Ġoffer 3.2726822
Ġnew 2.8909838
Ġhope 0.85654783
Ġfor 0.63179266
Ġlong 3.1643894
- 0.015013083
term 0.056133844
Ġremission 0.55236495
. 4.196267
Ċ 0.15724394
B 0.010908001
. 0.0007455852
ĠMr 0.7961559
. 0.002731615
ĠB 0.0059186216
's 0.10258089
ĠCase 0.118035346
: 0.057381887
Ċ 0.07947025
Mr 0.27833635
. 0.005098302
ĠB 0.006533926
, 1.3088651
Ġdiagnosed 4.0503936
Ġwith 0.07106828
Ġadvanced 2.0829098
Ġmelan 0.26180106
oma 0.00019988645
, 0.8558436
Ġexempl 6.9058485
ifies 0.07672105
Ġthe 0.19879635
Ġpotential 1.961954
Ġof 2.210943
Ġimmune 0.4207883
Ġcheckpoint 0.0039654523
Ġinhibitors 0.024626603
Ġto 2.5296335
Ġachieve 2.5713317
Ġremission 3.757752
. 1.7487699
ĠWith 3.7682674
Ġp 3.2927215
emb 0.0008480099
rol 0.0042339377
iz 0.0006422783
um 0.0019209511
ab 5.1810483e-05
Ġtreatment 1.483676
, 0.067674704
Ġhis 1.4064715
Ġtumor 0.8192334
Ġshr 2.2763703
inks 5.929655
Ġsignificantly 1.6908568
, 1.3202202
Ġleading 2.8780217
Ġto 0.05880592
Ġincreased 4.2812524
Ġoverall 3.686437
Ġsurvival 0.03691347
Ġand 1.6097736
Ġquality 1.5791833
Ġof 0.01563794
Ġlife 0.0025651748
. 0.11593222
Ċ 0.43224373
Conclusion 0.43338627
: 0.06248968
Ċ 0.04538968
The 2.0790594
Ġadvancements 2.4041827
Ġin 0.20523591
Ġimmune 1.7658168
Ġcheckpoint 0.023941224
Ġinhibitors 0.08098672
Ġand 0.031140195
Ġadj 0.012822682
u 0.0029261801
vant 0.00010271822
Ġtherapies 0.044147115
Ġhave 0.71048343
Ġrevolution 3.2243745
ized 0.0014576352
Ġmelan 1.2879902
oma 0.00023047146
Ġtreatment 0.46255618
, 0.9576582
Ġoffering 2.1147346
Ġimproved 3.5074906
Ġsurvival 1.1411746
Ġrates 0.1270606
Ġand 0.60241437
Ġthe 4.030759
Ġpotential 0.79674864
Ġfor 0.3032987
Ġlong 0.21128796
- 0.006040884
term 0.015904566
Ġremission 0.13451277
. 0.543571
ĠThese 1.9743757
Ġtreatments 0.7381683
Ġhave 1.5062402
Ġshown 3.8943584
Ġparticular 2.2994761
Ġefficacy 3.621721
Ġin 0.11062827
Ġpatients 0.7769625
Ġwith 0.0943837
Ġadvanced 0.04879096
Ġmelan 0.42051545
oma 0.014299308
, 0.54130906
Ġwhile 3.834042
Ġongoing 4.0031214
Ġresearch 0.49069002
Ġexplores 3.1865163
Ġtheir 0.38732383
Ġbenefits 3.2275736
Ġfor 2.2553627
Ġpatients 0.48688915
Ġat 0.6397133
Ġearlier 0.62388533
Ġstages 0.032214966
. 1.2630844
ĠThe 2.9610534
Ġcase 0.82437164
Ġof 0.04989541
ĠMr 0.00460908
. 0.00028114737
ĠB 0.003805029
Ġfurther 4.838931
Ġdemonstrates 1.9033899
Ġthe 0.13377547
Ġprofound 6.228802
Ġimpact 0.5265661
Ġthese 1.9919012
Ġtherapies 2.1631353
Ġcan 0.61436665
Ġhave 0.0539717
Ġon 0.2663308
Ġpatients 0.89426917
' 0.9967688
Ġlives 0.34454438
, 1.9369103
Ġinspiring 7.8647404
Ġhope 0.6353064
Ġfor 0.4265005
Ġa 1.9560956
Ġbrighter 2.1462612
Ġfuture 0.10331273
Ġin 1.5393318
Ġmelan 1.1913823
oma 0.000311554
Ġmanagement 4.941533
. 0.043102972
